Literature DB >> 2697981

Mitogenic regulation of normal and malignant breast epithelium.

M E Lippman1, R B Dickson.   

Abstract

The multiple roles of both estrogenic and polypeptide regulators of mammary epithelial cell growth are reviewed in this article. Effects of both steroidal and peptide hormones are complex and involve multiple interactions with malignant cells and non-malignant host components. Initial carcinogenesis and progression of mammary epithelium to cancer probably require both proliferative stimuli (estrogen, polypeptide growth factors) and genetic damage. This condition may lead to qualitatively different hormonal responses (hormone-responsive cancer). Estrogens can be shown to induce growth-regulatory polypeptide growth factors and interact with them in hormone-dependent breast cancer. Progression of hormone-dependent (estrogen-responsive) breast cancer to hormone independence probably involves multiple mechanisms, including oncogene activation, loss of the estrogen receptor, or loss of hormone responsivity of other gene products. One direction for further therapies may be blockade of hormonal stimulation and interference with necessary activated or induced components of malignant progression such as oncogenes or polypeptide growth factor-receptor systems.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2697981      PMCID: PMC2589165     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  196 in total

1.  Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal.

Authors:  S COHEN
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

Review 2.  Molecules involved in proliferation of normal and cancer cells: presidential address.

Authors:  A B Pardee
Journal:  Cancer Res       Date:  1987-03-15       Impact factor: 12.701

3.  Potential oncogene product related to growth factors.

Authors:  C Dickson; G Peters
Journal:  Nature       Date:  1987 Apr 30-May 6       Impact factor: 49.962

4.  Appearance of high affinity receptors for type beta transforming growth factor during differentiation of murine embryonal carcinoma cells.

Authors:  A Rizzino
Journal:  Cancer Res       Date:  1987-08-15       Impact factor: 12.701

Review 5.  Efforts to combine endocrine and chemotherapy in the management of breast cancer: do two and two equal three?

Authors:  M E Lippman
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

6.  Variables controlling somatomedin production by cultured human fibroblasts.

Authors:  D R Clemmons; D S Shaw
Journal:  J Cell Physiol       Date:  1983-05       Impact factor: 6.384

7.  Alterations in phosphoinositide metabolism associated with 17 beta-estradiol and growth factor treatment of MCF-7 breast cancer cells.

Authors:  C E Freter; M E Lippman; A Cheville; S Zinn; E P Gelmann
Journal:  Mol Endocrinol       Date:  1988-02

8.  Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease.

Authors:  M J Cline; H Battifora; J Yokota
Journal:  J Clin Oncol       Date:  1987-07       Impact factor: 44.544

9.  Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines.

Authors:  D D De Leon; B Bakker; D M Wilson; R L Hintz; R G Rosenfeld
Journal:  Biochem Biophys Res Commun       Date:  1988-04-15       Impact factor: 3.575

10.  Transformation of mouse BALB/c 3T3 cells with human basic fibroblast growth factor cDNA.

Authors:  R Sasada; T Kurokawa; M Iwane; K Igarashi
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

View more
  3 in total

1.  Tamoxifen prevents induction of hepatic neoplasia by zeranol, an estrogenic food contaminant.

Authors:  J E Coe; K G Ishak; J M Ward; M J Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

2.  A novel 80 kDa human estrogen receptor containing a duplication of exons 6 and 7.

Authors:  J J Pink; S Q Wu; D M Wolf; M M Bilimoria; V C Jordan
Journal:  Nucleic Acids Res       Date:  1996-03-01       Impact factor: 16.971

3.  Correlation of breast cancer risk factors with HER-2/neu protein overexpression according to menopausal and estrogen receptor status.

Authors:  Nikos Tsakountakis; Elias Sanidas; Efstathios Stathopoulos; Maria Kafousi; Nektaria Anogiannaki; Vasilis Georgoulias; Dimitris D Tsiftsis
Journal:  BMC Womens Health       Date:  2005-02-04       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.